Fast Five Quiz: Eosinophilic Asthma

Zab Mosenifar, MD


March 17, 2023

According to the GINA report "Global Strategy for Asthma Management and Prevention," higher blood eosinophils is a strong predictor of a good response to targeted biologic therapy. Add-on biologics that target interleukin (IL-5, IL-5R, and IL-4) receptors are approved for use in different age groups by subcutaneous injection. The same GINA report provides specific guidance on eligibility and dosing.

Learn more about treatment recommendations for EA.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.